Skip to content
AnalystLens

CME GROUP INC. Quarterly Report for Q2 Ended Jun 30, 2017

Filing Date
Filed August 2, 2017
Period End
June 30, 2017
Security
CME
In the record · 2016–202610-K1110-Q328-K119

CME filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 119 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Feb ’20Feb ’20
  2. Material agreement8-K · Apr ’22Apr ’22
  3. Leadership change8-K · Sep ’26Sep ’26

Summary

Summary of the 10-Q filed August 2, 2017. Cited figures are marked; the original filing is the authoritative source.

CME Group Inc. reported solid financial results for the second quarter and the first six months of 2017, demonstrating resilience and growth.

Total revenues saw a modest increase, driven primarily by a 3%a rise in clearing and transaction fees for the quarter and a 1% increase for the six-month period, indicating robust trading activity. While average rates per contract saw a slight decline, this was more than offset by a significant increase in contract volume, particularly in interest rate and energy products. The company also managed its expenses effectively, with total operating expenses decreasing by 7% and 8% for the respective periods, primarily due to lower professional fees, reduced rent, and favorable foreign currency exchange rate fluctuations.

Net income experienced a substantial increase of 30%b for the quarter and 19% for the six-month period, leading to a healthy rise in diluted earnings per share. This strong performance was further bolstered by a significant increase in non-operating income, largely due to higher investment income from reinvested collateral and a gain from the sale of BM&FBOVESPA shares. The company maintains a strong liquidity position with substantial cash flows from operations and significant credit facilities available, underscoring its financial stability.

Key Highlights

  1. Revenue increased by 2% to $924.6 million in Q2 2017 and by 1% to $1,853.9 million in the first six months of 2017, driven by clearing and transaction fees.
  2. Clearing and transaction fees grew 3% to $792.0 million in Q2 2017 and 1% to $1,584.0 million in the first six months of 2017, supported by a 7% and 5% increase in contract volume respectively.
  3. Total operating expenses decreased by 7% to $319.0 million in Q2 2017 and by 8% to $647.1 million in the first six months of 2017, benefiting from lower professional fees and favorable foreign currency fluctuations.
  4. Net income surged by 30% to $415.8 million in Q2 2017 and by 19% to $815.6 million in the first six months of 2017.
  5. Diluted earnings per share increased by 28% to $1.22 in Q2 2017 and by 18% to $2.40 in the first six months of 2017.
  6. Strong performance in interest rate (up 21% daily volume in Q2) and energy products (up 13% daily volume in Q2) contributed to overall volume growth.
  7. Non-operating income saw a significant increase due to higher investment income and a gain from the sale of BM&FBOVESPA shares.

Financial Statements

Q2 FY2017 against Q2 FY2016

Line itemQ2 FY2017Q2 FY2016Change
Revenue$924.60M$906.40M+2.0%
Operating Expenses$319.40M$343.10M−6.9%
Operating Income$605.20M$563.30M+7.4%
Net Income$415.80M$320.10M+29.9%
EPS (Basic)$1.23$0.95+29.5%
EPS (Diluted)$1.22$0.95+28.4%
Shares Outstanding (Basic)338.56M337.29M+0.4%
Shares Outstanding (Diluted)340.02M338.71M+0.4%

Frequently Asked Questions

  1. What was the primary driver of revenue growth for CME Group in Q2 2017?

    The primary driver of revenue growth was the increase in clearing and transaction fees, which rose by 3% to $792.0 million in the second quarter of 2017. This growth was supported by a 7% increase in total contract volume, indicating higher trading activity across CME Group's platforms.

  2. How did CME Group manage its expenses during the period?

    CME Group effectively managed its expenses, with total operating expenses decreasing by 7% to $319.0 million in Q2 2017 compared to the prior year. Key contributing factors to this decrease included lower professional fees and outside services, reduced occupancy and building operations costs, and favorable foreign currency exchange rate fluctuations.

  3. What is the outlook for CME Group's key product lines based on contract volume trends?

    The company saw strong growth in interest rate products (21% increase in average daily volume for Q2 2017) and energy products (13% increase in average daily volume for Q2 2017), driven by market volatility and supply shifts. Equity and agricultural commodity volumes experienced declines, attributed to lower market volatility in those sectors.

  4. How is CME Group's liquidity and financial position?

    CME Group maintains a strong liquidity position. Net cash provided by operating activities increased by 9% in the first six months of 2017. The company also has significant credit facilities available, including a $2.3 billion multi-currency revolving senior credit facility and a $7.0 billion 364-day multi-currency revolving secured credit facility, demonstrating robust financial flexibility.